APAC In-Vitro Fertilization (IVF) Market Share, Trends, Growth Drivers, Revenue,Challenges, Opportunities and Forecast Research Report 2033

Share

APAC In-Vitro Fertilization (IVF) Market Share, Trends, Growth Drivers, Revenue,Challenges, Opportunities and Forecast Research Report 2033: SPER Market Research


 Category : Healthcare

 Published: Feb-2024
 Author: SPER Analyst


Asia-Pacific In-Vitro Fertilization (IVF) Market is projected to be worth USD 63.52 Billion by 2033 with a CAGR of 17.24%.

In vitro fertilisation (IVF) is a technique in assisted reproductive technology (ART) whereby sperm fertilises egg cells outside of the woman's body, and the resulting embryo or embryos are then inserted into the uterus. In order to help with conception, this procedure is used to correct genetic or reproductive problems. It includes removing eggs and retrieving sperm cells, then manually combining them in a lab to create embryos. After that, these embryos are placed into the uterus to continue developing. IVF is a common tool used to help individuals and couples, including LGBT people, single mothers, and those with infertility issues.

Asia-Pacific In-Vitro Fertilization (IVF) Market Driving Factors and Challenges

The use of IVF services is, however, constrained by side effects of the procedure, such as multiple pregnancies and birth problems. Many pregnancies may result with IVF, as success rates are dependent on the quantity of embryos transferred. High blood pressure and delivery problems are among the issues that result from having several pregnancies. Premature birth and low birth weight are two additional health issues that a kid may experience as a result of many pregnancies. Additionally, an ectopic pregnancy—where the embryo is implanted outside the woman's womb and causes potentially fatal circumstances—is another risk that comes with IVF treatment. The expansion of the market is impeded by these constraints, which restrict the use of IVF operations.


Impact of COVID-19 on Asia-Pacific In-Vitro Fertilization (IVF) Market
The increased acceptability of IVF operations, technological improvements that increase success rates, and public awareness of the advantages of IVF are some of the reasons driving the considerable growth of the Asia-Pacific IVF services market. Improved IVF success rates can be attributed to technological breakthroughs such as in vitro maturation (IVM), intracytoplasmic sperm injection (ICSI), and pre-implantation genetic diagnosis (PGD). Increased use of IVF procedures has also been attributed to higher levels of disposable money, especially among middle-aged couples in solid socioeconomic situations. IVF cycles and drugs are expensive, but infertile couples are drawn to the process because of its growing success rate. Infertility is also fueled by lifestyle variables like smoking, binge drinking, obesity, emotional stress, PCOS, and fallopian tube obstruction, which drives the demand for IVF services in the Asia-Pacific area. 

The Asia-Pacific IVF services industry is expected to grow more slowly as a result of the COVID-19 pandemic. Numerous nations implemented lockdowns at the national level, which had a direct effect on fertility tourism as a result of aircraft delays, travel restrictions and quarantines, cancellation of all indoor and outdoor events, and emergency declarations. A great deal of clinics and hospitals underwent structural changes in order to accommodate more COVID-19 patients. Due to doctors' direct interaction with patients seeking IVF therapy, non-urgent patient visits to fertility clinics were discouraged, and elective fertility treatments were delayed. These elements therefore caused the cancellation of numerous planned IVF treatments and were predicted to impede the expansion of the Asia-Pacific IVF market throughout the pandemic.

Asia-Pacific In-Vitro Fertilization (IVF) Market Key Players:
The market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as; Alcon, Bausch Health Companies Inc., Carl Zeiss AG, Cooper Companies, Johnson & Johnson, MaxiVision Eye Hospital, Rayner Surgical Group Limited, Schwind eye-tech-solutions GmbH & co.kg., STAAR Surgical Company, Ziemer Group AG, Others.


Asia-Pacific In-Vitro Fertilization (IVF) Market Segmentation:

By Cycle Type: Based on the Cycle Type, Asia-Pacific In-Vitro Fertilization (IVF) Market is segmented as; Donor Egg IVF Cycle, Fresh Cycle (Non-Donor), Thawed IVF Cycle (Non-Donor).

By End User: Based on the End User, Asia-Pacific In-Vitro Fertilization (IVF) Market is segmented as; Clinical Research Institutes, Fertility Clinics, Hospitals, Surgical Centers.

By Region: This research also includes data for Australia, China, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Thailand, Vietnam, Rest of Asia-Pacific.

This study also encompasses various drivers and restraining factors of this market for the forecast period. Various growth opportunities are also discussed in the report.

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-PWC
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-PWC

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1 iso-1 ESOMAR
Secure Payments
SPER Payment Options
Contact HR

 [email protected]

 +91-742-898-5650